Get started
Author

Fisihatsion Tadesse

Observed names: Fishatsion Tadesse, Fissehatsion Tadesse, Fissehatsion Tadesse Woldegebriel, Tadesse, Fisihatsion
ORCID: 0000-0003-4270-9424
Observed ORCID: 0000-0003-4270-9424
OpenAlex ID: A5055047186
Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian’s with chronic myeloid leukemia
2019 · Atalay Mulu Fentie, Fishatsion Tadesse, et al. · PLoS ONE · 27
PDF
Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia
2021 · Fisihatsion Tadesse, Getahun Asres, et al. · JCO Global Oncology · 22
Clinical presentation and diagnosis of adult patients with non‐Hodgkin lymphoma in Sub‐Saharan Africa
2020 · Nikolaus C. S. Mezger, Jana Feuchtner, et al. · British Journal of Haematology · 21
PDF
Clinical Characteristics and Histopathological Patterns of Hodgkin Lymphoma and Treatment Outcomes at a Tertiary Cancer Center in Ethiopia
2021 · Makka Adam, Yonas Bekueretsion, et al. · JCO Global Oncology · 16
PDF
Drug-related problems and potential contributing factors in the management of deep vein thrombosis
2016 · Fekede Bekele Daba, Fisihatsion Tadesse, et al. · BMC Hematology · 8
PDF
Attitude, Perceived Barriers, and Challenges Toward Implementing Resource-Appropriate Guidelines for Hematologic Malignancies: Physicians' Survey in Ethiopia
2023 · Obsie T. Baissa, Workagegnehu Hailu, et al. · JCO Global Oncology · 7
PDF
Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort
2023 · Nikolaus Christian Simon Mezger, Lucia Hämmerl, et al. · The Oncologist · 6
PDF
Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study
2024 · Fekadu Urgessa, Boki Lengiso, et al. · BMC Cancer · 5
PDF
Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study
2024 · Seble Birhane, Melak Gedamu Beyene, et al. · Thrombosis Journal · 4
Detection and Quantification of the Epstein-Barr Virus in Lymphoma Patients from Ethiopia: Molecular and Serological Approaches
2023 · Seifegebriel Teshome, Kidist Zealiyas, et al. · Microorganisms · 4
PDF
Genotypes Distribution of Epstein–Barr Virus among Lymphoma Patients in Ethiopia
2023 · Seifegebriel Teshome, Elshafa Hassan Ahmed, et al. · International Journal of Molecular Sciences · 4
PDF
Frequency of viral infections in adolescent and adult in-patient Ethiopians with acute leukemia at presentation to a tertiary care teaching hospital: a cross-sectional study
2023 · Jemal Alemu, Balako Gumi, et al. · Infectious Agents and Cancer · 4
PDF
Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study
2024 · Fisihatsion Tadesse, Francesco Sparano, et al. · JCO Global Oncology · 3
Diagnostic Utility of Immunophenotyping by Flow Cytometry for Diagnosis and Classification of Acute Leukemias in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
2021 · Metasebia Tegegen, Fatuma Hassen, et al. · Indonesian Journal of Cancer · 3
PDF
Prevalence and risk factors of Helicobacter pylori among adults at Jinka zonal hospital, Debub Omo Zone, Southwest Ethiopia
2016 · Getnet Hailu Kassu Desta, Fisihatsion Tadesse · Journal of Bacteriology & Parasitology · 3
Unveiling the nephrotoxic profile of BCR‐ABL tyrosine kinase inhibitors: A real‐world experience in Africa
2024 · Zekarias Seifu Ayalew, Gebeyehu Tessema Azibte, et al. · eJHaem · 2
PDF
Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitor Drugs
2024 · Samuel Kinde Birru, Ilias Doxiadis, et al. · Genes · 2
PDF
Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings
2023 · Saifu Hailu, Samuel Kinde, et al. · Annals of Hematology · 2
PDF
Occupational, Lifestyle, and Medical Risk Factors for Non-Hodgkin Lymphoma: A Case–Control Study in Ethiopia
2025 · Obsie T. Baissa, Fozia Abdela, et al. · Cancers · 1
PDF
MicroRNAs as prognostic and predictive biomarkers among chronic myeloid leukemia patients in Addis Ababa, Ethiopia
2025 · Fekadu Urgessa, Isaac Jenkins, et al. · Scientific Reports · 1
PDF
Subarachnoid haemorrhage in a newly diagnosed Chronic Myelogenous Leukemia patient: A diagnostic challenge
2024 · Zekewos Demissie, Brook Alemayehu, et al. · Ethiopian Medical Journal · 1
PDF
Demographic profile, risk stratification, clinical characteristics, and treatment outcome of patients with multiple myeloma: A five-year retrospective study at a tertiary hospital in Ethiopia
2023 · Ephrem Haile, Adugna Tasew, et al. · medRxiv · 1
PDF
Incidence of Acute Transfusion Reaction and its Associated Risk Factors in Ateritiary Care Center in Ethiopia
2023 · Temesgen Assefa Ayele *, Fissehatsion Tadesse · International Journal of Clinical Research and Reports · 1
PDF
POSTER: CLL-1118: Early Outcomes of a Multistakeholder Treatment Access Program for Chronic Lymphocytic Leukemia in Armenia, Ethiopia, and Nepal
2026 · Lauren Herzog, Alicia Annamalay, et al. · Clinical Lymphoma Myeloma & Leukemia
CLL-1118: Early Outcomes of a Multistakeholder Treatment Access Program for Chronic Lymphocytic Leukemia in Armenia, Ethiopia, and Nepal
2026 · Lauren Herzog, Alicia Annamalay, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 39
Citation count: 148
H-index: 6
I10-index: 4
Year
Topic
Type